Publications

Population-Level Risk Factors Related to Measles Case Fatality: A Conceptual Framework Based on Expert Consultation and Literature Review.

Sbarra, AN; JIT, M; Mosser, JF; Ferrari, M; Cutts, F; Papania, M; Kretsinger, K; McCarthy, KA; Thakkar, N; Gaythorpe, KA M; Gamage, D; Krause, LK; Dansereau, E; Crowcroft, N; Portnoy, A;

2023

Vaccines, (2023).11 8 10.3390/vaccines11081389.

Cost-effectiveness of pharmaceutical strategies to prevent respiratory syncytial virus disease in young children: a decision-support model for use in low-income and middle-income countries.

Mahmud, S; Baral, R; Sanderson, C; Pecenka, C; JIT, M; Li, Y; CLARK, A;

2023

BMC medicine, (2023).21 1 10.1186/s12916-023-02827-5.

Reconstructing the phylodynamic history and geographic spread of the CRF01_AE-predominant HIV-1 epidemic in the Philippines from PR/RT sequences sampled from 2008 to 2018.

Polotan, FG M; Salazar, CR P; Morito, HL E; Abulencia, MF B; Pantoni, RA R; Mercado, ES; Hué, S; Ditangco, RA;

2023

Virus evolution, (2023).9 2 10.1093/ve/vead073.

Superior immunogenicity of mRNA over adenoviral vectored COVID-19 vaccines reflects B cell dynamics independent of anti-vector immunity: Implications for future pandemic vaccines.

Liu, Y; Sánchez-Ovando, S; Carolan, L; Dowson, L; Khvorov, A; Jessica Hadiprodjo, A; Tseng, YY; Delahunty, C; Khatami, A; Macnish, M; Dougherty, S; Hagenauer, M; Riley, KE; Jadhav, A; Harvey, J; Kaiser, M; Mathew, S; HODGSON, D; Leung, V; Subbarao, K; Cheng, AC; Macartney, K; Koirala, A; Marshall, H; Clark, J; ... Fox, A.

2023

Vaccine, (2023).41 48 10.1016/j.vaccine.2023.10.034.

Spatio-Temporal Patterns and Surveillance of Infectious Disease During Emergence and Elimination.

NIGHTINGALE, ES;

2023

(2023). 10.17037/PUBS.04671120.

Protocol for an OpenSAFELY cohort study collecting patient-reported outcome measures using the TPP Airmid smartphone application and linked big data to quantify the health and economic costs of long COVID (OpenPROMPT).

HERRETT, E; TOMLIN, K; LIN, L-Y; TOMLINSON, LA; JIT, M; BRIGGS, A; MARKS, M; Sandmann, F; Parry, J; Bates, C; Morley, J; Bacon, S; Butler-Cole, B; MAHALINGASIVAM, V; Dennison, A; Smith, D; Gabriel, E; Mehrkar, A; GOLDACRE, B; SMEETH, L; EGGO, RM M;

2023

BMJ Open, (2023).13 2 10.1136/bmjopen-2022-071261.

PIF influenza costing analysis and probabilistic sensitivity analysis.

Tang, FF-Y; Kosana, P; JIT, M; TERRIS-PRESTHOLT, F; WU, D; Ong, JJ; TUCKER, JD;

2023

, PLOS Global Public Health (2023).

An Aspiration to Radically Shorten Phase 3 Tuberculosis Vaccine Trials.

Hill, PC; Cobelens, F; Martinez, L; Behr, MA; Churchyard, G; Evans, T; Fiore-Gartland, AJ; Garcia-Basteiro, AL; Hanekom, W; Rangaka, MX; Vekemans, J; WHITE, RG;

2023

The Journal of infectious diseases, (2023).228 9 10.1093/infdis/jiad356.

Predicting subnational incidence of COVID-19 cases and deaths in EU countries.

ROBERT, A; Chapman, LA C; Grah, R; Niehus, R; Sandmann, F; Prasse, B; FUNK, S; KUCHARSKI, A;

2023

medRxiv (2023). 10.1101/2023.08.11.23293400.

Estimating national-level measles case-fatality ratios in low-income and middle-income countries: an updated systematic review and modelling study.

SBARRA, AN; Mosser, JF; JIT, M; Ferrari, M; Ramshaw, RE; O'Connor, P; Krause, LK; Rogowski, EL B; Portnoy, A;

2023

The Lancet. Global health, (2023).11 4 10.1016/s2214-109x(23)00043-8.